Abstract:Circulation Research, Ahead of Print. BACKGROUND:Genome-wide association studies implicate common genetic variations in theLRP1(low-density lipoprotein receptor-related protein 1) locus at risk for multiple vascular diseases and traits. However, the underlying biological mechanisms are unknown.METHODS:Fine mapping analyses included Bayesian colocalization to identify the most likely causal variant. Human induced pluripotent stem cells were genome-edited using CRISPR-Cas9 to delete or modify candidate enhancer regions and generateLRP1knockout cell lines. Cells were differentiated into smooth muscle cells through a mesodermal lineage. Transcription regulation was assessed using luciferase reporter assay, transcription factor knockdown, and chromatin immunoprecipitation. Phenotype changes in cells were conducted using cellular assays, bulk RNA sequencing, and mass spectrometry.RESULTS:Multitrait colocalization analyses pointed at rs11172113 as the most likely causal variant inLRP1for fibromuscular dysplasia, migraine, pulse pressure, and pulmonary function trait. We found the rs11172113-T allele to associate with higherLRP1expression. Genomic deletion in induced pluripotent stem cell–derived smooth muscle cells supported rs11172113 to locate in an enhancer region regulatingLRP1expression. We found transcription factors MECP2 (methyl CpG binding protein 2) and SNAIL to repressLRP1expression through an allele-specific mechanism, involving SNAIL interaction with disease risk allele.LRP1knockout decreased induced pluripotent stem cell–derived smooth muscle cell proliferation and migration. Differentially expressed genes were enriched for collagen-containing extracellular matrix, connective tissue development, and lung development.LRP1knockout and deletion of rs11172113 enhancer showed potentiated canonical TGF-β (transforming growth factor beta) signaling through enhanced phosphorylation of SMAD2/3. Analyses of the protein content of decellularized extracts indicated partial extracellular matrix remodeling involving enhanced secretion of CYR61, a known LRP1 ligand involved in vascular integrity and TIMP3, implicated in extracellular matrix maintenance and also known to interact with LRP1.CONCLUSIONS:Our findings support allele-specificLRP1gene repression by the endothelial-to-mesenchymal transition regulator SNAIL. We propose decreasedLRP1expression in smooth muscle cells to remodel the extracellular matrix enhanced by TGF-β as a potential mechanism of this pleiotropic locus for vascular diseases.

Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon

A patient-enriched MEIS1 coding variant causes a restless legs syndrome-like phenotype in mice

Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions

Intronic elements associated with insomnia and restless legs syndrome exhibit cell-type-specific epigenetic features contributing to MEIS1 regulation

Replication of restless legs syndrome loci in three European populations

MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease

Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population.

Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12. 1

Genomic Analysis Identifies Risk Factors in Restless Legs Syndrome

Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction

A splice acceptor variant in RGS6 associated with intellectual disability, microcephaly, and cataracts disproportionately promotes expression of a subset of RGS6 isoforms

Affinity-optimizing enhancer variants disrupt development

A functional schizophrenia-associated genetic variant near the TSNARE1 and ADGRB1 genes

Identification of Causal Genes and Potential Drug Targets for Restless Legs Syndrome: A Comprehensive Mendelian Randomization Study

Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome

Genomewide Linkage Scan Identifies A Novel Susceptibility Locus For Restless Legs Syndrome On Chromosome 9p

PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome

LRP1 Repression by SNAIL Results in ECM Remodeling in Genetic Risk for Vascular Diseases

Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors

De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features

Association of BTBD9 and MAP2K5/SKOR1 with Restless Legs Syndrome in Chinese Population.